275 related articles for article (PubMed ID: 35040616)
1. Macrophage-Mimic Hollow Mesoporous Fe-Based Nanocatalysts for Self-Amplified Chemodynamic Therapy and Metastasis Inhibition
Zuo W; Chen W; Liu J; Huang S; Chen L; Liu Q; Liu N; Jin Q; Li Y; Wang P; Zhu X
ACS Appl Mater Interfaces; 2022 Feb; 14(4):5053-5065. PubMed ID: 35040616
[TBL] [Abstract][Full Text] [Related]
2. Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy.
Zuo W; Fan Z; Chen L; Liu J; Wan Z; Xiao Z; Chen W; Wu L; Chen D; Zhu X
Acta Biomater; 2022 Jul; 147():258-269. PubMed ID: 35605954
[TBL] [Abstract][Full Text] [Related]
3. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO
Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R
Acta Biomater; 2024 May; ():. PubMed ID: 38801869
[TBL] [Abstract][Full Text] [Related]
4.
Li T; He F; Liu B; Jia T; Shao B; Zhao R; Zhu H; Yang D; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56886-56897. PubMed ID: 33290033
[TBL] [Abstract][Full Text] [Related]
5. Phosphate-Degradable Nanoparticles Based on Metal-Organic Frameworks for Chemo-Starvation-Chemodynamic Synergistic Antitumor Therapy.
Peng H; Qin YT; Feng YS; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2021 Aug; 13(31):37713-37723. PubMed ID: 34340302
[TBL] [Abstract][Full Text] [Related]
6. Dual-Responsive and ROS-Augmented Nanoplatform for Chemo/Photodynamic/Chemodynamic Combination Therapy of Triple Negative Breast Cancer.
Chen M; Yang J; Zhou L; Hu X; Wang C; Chai K; Li R; Feng L; Sun Y; Dong C; Shi S
ACS Appl Mater Interfaces; 2022 Jan; 14(1):57-68. PubMed ID: 34935343
[TBL] [Abstract][Full Text] [Related]
7. Hollow Porous Carbon Coated FeS
Wu F; Zhang Q; Zhang M; Sun B; She Z; Ge M; Lu T; Chu X; Wang Y; Wang J; Zhou N; Li A
ACS Appl Mater Interfaces; 2020 Mar; 12(9):10142-10155. PubMed ID: 32043350
[TBL] [Abstract][Full Text] [Related]
8. Nanocatalyst-Mediated Chemodynamic Tumor Therapy.
Zhang L; Li CX; Wan SS; Zhang XZ
Adv Healthc Mater; 2022 Jan; 11(2):e2101971. PubMed ID: 34751505
[TBL] [Abstract][Full Text] [Related]
9. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
Carradori S
Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
[TBL] [Abstract][Full Text] [Related]
10. Tumor acidification and GSH depletion by bimetallic composite nanoparticles for enhanced chemodynamic therapy of TNBC.
Chen W; Hu F; Gao Q; Zheng C; Bai Q; Liu J; Sun N; Zhang W; Zhang Y; Dong K; Lu T
J Nanobiotechnology; 2024 Mar; 22(1):98. PubMed ID: 38461231
[TBL] [Abstract][Full Text] [Related]
11. Pillar[6]arene-Based Supramolecular Nanocatalysts for Synergistically Enhanced Chemodynamic Therapy by the Intracellular Cascade Reaction.
Liu X; Liu J; Meng C; Zhu P; Liu X; Qian J; Ling S; Zhang Y; Ling Y
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53574-53585. PubMed ID: 34729975
[TBL] [Abstract][Full Text] [Related]
12. Iron-Based Theranostic Nanoplatform for Improving Chemodynamic Therapy of Cancer.
Liu X; Jin Y; Liu T; Yang S; Zhou M; Wang W; Yu H
ACS Biomater Sci Eng; 2020 Sep; 6(9):4834-4845. PubMed ID: 33455215
[TBL] [Abstract][Full Text] [Related]
13. Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy.
Tang W; Gao H; Ni D; Wang Q; Gu B; He X; Peng W
J Nanobiotechnology; 2019 May; 17(1):68. PubMed ID: 31109332
[TBL] [Abstract][Full Text] [Related]
14. Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX.
Dvořanová J; Kugler M; Holub J; Šícha V; Das V; Nekvinda J; El Anwar S; Havránek M; Pospíšilová K; Fábry M; Král V; Medvedíková M; Matějková S; Lišková B; Gurská S; Džubák P; Brynda J; Hajdúch M; Grüner B; Řezáčová P
Eur J Med Chem; 2020 Aug; 200():112460. PubMed ID: 32505851
[TBL] [Abstract][Full Text] [Related]
15. PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX.
Mondal UK; Doroba K; Shabana AM; Adelberg R; Alam MR; Supuran CT; Ilies MA
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498779
[TBL] [Abstract][Full Text] [Related]
16. Hollow mesoporous MnO
He H; Yang Q; Li H; Meng S; Xu Z; Chen X; Sun Z; Jiang B; Li C
Mikrochim Acta; 2021 Mar; 188(4):141. PubMed ID: 33774694
[TBL] [Abstract][Full Text] [Related]
17. Tumor Microenvironment-Activated Nanoparticles Loaded with an Iron-Carbonyl Complex for Chemodynamic Immunotherapy of Lung Metastasis of Melanoma
Zhai T; Zhong W; Gao Y; Zhou H; Zhou Z; Liu X; Yang S; Yang H
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39100-39111. PubMed ID: 34382406
[TBL] [Abstract][Full Text] [Related]
18. Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions.
Tang Z; Liu Y; He M; Bu W
Angew Chem Int Ed Engl; 2019 Jan; 58(4):946-956. PubMed ID: 30048028
[TBL] [Abstract][Full Text] [Related]
19. Construction and evaluation of a nanosystem that combines acidification promoted chemodynamic therapy and intracellular drug release monitoring.
Dong K; Wang D; Lin L; Niu P; Wang Y; Tan Q; Xing J
J Biotechnol; 2024 Mar; 383():13-26. PubMed ID: 38325656
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional nanosystems sequentially regulating intratumor Fenton chemistry by remodeling the tumor microenvironment to reinforce chemodynamic therapy.
Dong K; Chen W; Zhao Z; Zhang Y; Wang P; Wang K; Xing J; Lu T; Dong Y
Biomater Adv; 2022 Jul; 138():212957. PubMed ID: 35913243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
